NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...
This omission raises critical questions about our ability as a people to advocate for our rightful place in the national spotlight and demand recognition for the contributions of our island’s ...